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Abstract
Background: The development of the Nisin Inducible Controlled Expression (NICE) system in the food-grade
bacterium Lactococcus lactis subsp. cremoris represents a cornerstone in the use of Gram-positive bacterial
expression systems for biotechnological purposes. However, proteins that are subjected to such over-expression in
L. lactis may suffer from improper folding, inclusion body formation and/or protein degradation, thereby
significantly reducing the yield of soluble target protein. Although such drawbacks are not specific to L. lactis,n o
molecular tools have been developed to prevent or circumvent these recurrent problems of protein expression in
L. lactis.
Results: Mimicking thioredoxin gene fusion systems available for E. coli, two nisin-inducible expression vectors
were constructed to over-produce various proteins in L. lactis as thioredoxin fusion proteins. In this study, we
demonstrate that our novel L. lactis fusion partner expression vectors allow high-level expression of soluble
heterologous proteins Tuc2009 ORF40, Bbr_0140 and Tuc2009 BppU/BppL that were previously insoluble or not
expressed using existing L. lactis expression vectors. Over-expressed proteins were subsequently purified by Ni-TED
affinity chromatography. Intact heterologous proteins were detected by immunoblotting analyses. We also show
that the thioredoxin moiety of the purified fusion protein was specifically and efficiently cleaved off by
enterokinase treatment.
Conclusions: This study is the first description of a thioredoxin gene fusion expression system, purposely
developed to circumvent problems associated with protein over-expression in L. lactis. It was shown to prevent
protein insolubility and degradation, allowing sufficient production of soluble proteins for further structural and
functional characterization.
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Background
The food-grade bacterium L. lactis subsp. cremoris in
conjunction with the Nisin Inducible Controlled Expres-
sion (NICE) system [1-3] has been extensively used over
the last few decades as a valuable bacterial expression
system for large-scale production of homologous or het-
erologous proteins [4], metabolic studies [5], or mem-
brane proteins [6]. The NICE system is based on the
well characterized nisin-dependent, quorum-sensing
mechanism of L. lactis [2,3,7]. It was initially exploited
in L. lactis for heterologous protein overexpression and
subsequently implemented in several other Gram-posi-
tive bacteria [2,3,7-10]. Typically, the genetically-engi-
neered strain L. lactis subsp. cremoris NZ9000 is
employed as expression host, as its chromosome con-
tains the signal transduction genes nisR and nisK
involved in the nisin-induced transcriptional control of
the PnisA promoter [3]. Any genes cloned downstream
this nisin-inducible promoter PnisA can be expressed in
a controlled manner upon addition of nisin to the bac-
terial culture [3]. However, production of recombinant
proteins can be problematic in L. lactis,a so v e r -
expressed proteins may be subject to poor expression,
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cally associated with the prokaryotic cell machinery lim-
itations and therefore are inherent to all bacterial
expression systems, representing a significant bottleneck
in high level production of soluble proteins.
In E. coli,a‘microbial cell factory’ of choice for produ-
cing heterologous proteins [11,12], the development of the
gene fusion technology proved to circumvent such recur-
rent and fundamental protein expression problems [13].
This technology involves the linkage of the protein of inter-
est with a carrier protein to generate a fusion protein.
Addressing solutions to problematic protein expressions,
many fusion expression systems have been engineered and
successfully employed, using solubility-enhancing fusion
partners such as Schistosoma japonicum glutathione-S-
transferase (GST) [14], E. coli maltose binding proteins
(MBP) [15], Staphylococcus protein A [16], E. coli N-utili-
zation substance (NusA) [17] and E. coli thioredoxin
(TrxA) [18,19]. Along with the increasing number of fusion
partners used, additional features have been successfully
implemented to this technology, thus facilitating protein
tagging, purification techniques and tag-mediated proteoly-
tic cleavage [13,20,21]. The gene fusion technology pro-
vides a substantial palette of applications through the
constant expansion of fusion gene expression systems
available in E. coli. Nevertheless, the adaptation of these
existing fusion partner systems to other expression hosts is
sparse, even though significant progress has been made to
develop new molecular tools and methods in alternative
prokaryotic and eukaryotic expression systems [1,22,23].
The expression host L. lactis is currently lacking such a
solubility-enhancing expression system to improve its spec-
trum of biotechnological applications, as L. lactis featured a
number of benefits over other expression bacterial hosts, e.
g. being a food-grade expression host, and the absence of
endotoxins, extracellular proteinases and spores.
As part of our study on the structure-function analysis
of lactococcal phage-host recognition and penetration,
we attempted to over-express a number of proteins
encoded by the lactococcal phage Tuc2009 in L. lactis.
However, initial expression studies of individual protein
subunits of Tuc2009 phage revealed such proteins often
suffer from degradation, poor expression or result in
insoluble protein aggregates, also called inclusion bodies
(data not shown). The development of a fusion-based
gene expression system in L. lactis could provide a
novel strategy to express soluble proteins and avoid the
use of laborious and spurious renaturation procedures.
Among the numerous fusion partners employed, LaVal-
lie et al. described the construction of an E. coli thiore-
doxin (TrxA) gene fusion system [19]. In most cases, E.
coli thioredoxin fusion proteins were soluble, correctly
folded and biologically active [19]. The E. coli thiore-
doxin thus appears to represent a good candidate for an
L. lactis fusion-based gene expression system: small size
of the fusion partner (11.67 kDa), ability to accumulate
in a soluble form at high levels in the cytoplasm, steric
accessibility of N- and C-termini of TrxA for protein
fusions [19] and efficient generic protein purification
methods available, i.e. immunoprecipitation or affinity
chromatography [13,24].
In the present study, we report on the construction of
two new L. lactis thioredoxin-fusion gene expression
vectors harbouring the nisin-controlled expression
(NICE) system. We evaluated the efficiency of the
newly-constructed fusion gene expression system, by
producing individual proteins or protein complexes that
initially could not be expressed or were not soluble in L.
lactis. Our data indicate that the L. lactis thioredoxin-
fusion vectors represent a very valuable addition to the
L. lactis genetic toolbox, in particular for the over-pro-
duction of soluble proteins.
Methods
Bacterial strains, media, growth conditions and nisin
preparation
Bacterial strains described in this study are listed in
Table 1. L. lactis subsp. cremoris NZ9000 [3] and
NZ9700 [3,6,7] were cultured at 30°C under static con-
ditions in GM17 broth (M17 broth [25]; Oxoid, UK)
with 0.5% (w/v) D-glucose (Sigma)). L. lactis transfor-
mants were selected on GM17 agar plates supplemented
with 5 μg/ml chloramphenicol (Sigma). The supernatant
from overnight cultures of the nisin-producing strain L.
lactis NZ9700 was filter-sterilized and used in this study
as a source of the inducer nisin [6].
DNA amplification and cloning
Oligonucleotide primers were purchased from Eurofins
MWG GmbH (Germany) and are listed in Table 2. Geno-
mic DNA from Tuc2009 or B. breve UCC2003 was
extracted as previously described [26,27]. Plasmids and pri-
mers are listed in Tables 1 and 2, respectively. High-fidelity
hot start KOD DNA polymerase (Novagen, UK), restriction
enzymes (Roche GmbH, Germany) and T4 DNA ligase
(Promega, USA) were used as recommended by the rele-
vant manufacturers. Plasmid DNA was electroporated into
L. lactis NZ9000 as described by Holo et al.[ 2 8 ] .
Construction of thioredoxin gene fusion expression
vectors
The two expression vectors constructed in this study,
called pTX8048 and pTX8049, are derived from the
high-copy number vector pNZ8048 harbouring the
NICE system and a chloramphenicol resistance marker
[3]. The high-copy number expression vector pTX8048
was constructed as follows. The DNA fragment contain-
ing the E. coli trxA gene was amplified from the
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Strains or plasmids Relevant characteristics Reference or source
Strains
L. lactis
NZ9000 MG1363 containing nisRK genes, [3]
NZ9700 expression host of the NICE system
Nisin producing L. lactis strain
[3,7]
Plasmids
pNZ8048 Standard L. lactis expression vector, Cm
r [3]
pTX8048 pNZ8048 derivative harbouring the TrxA system, contains a His-tag cloned in frame This study
pTX8049 pNZ8048 derivative harbouring the TrxA system This study
pNZ8048-UAL pNZ8048 encoding Tuc2009 bppU, bppA, bppL as an operon This study
pTX8048-UAL pTX8048 encoding Tuc2009 bppU, bppA, bppL as an operon This study
pNZ8048-40 pNZ8048 encoding Tuc2009 orf40 This study
pTX8048-40 pTX8048 encoding Tuc2009 orf40 This study
pNZ8048-0140N pNZ8048 encoding N-terminal His-tagged Bbr_0140 This study
pNZ8048-0140C pNZ8048 encoding C-terminal His-tagged Bbr_0140 This study
pTX8048-0140 pTX8048 encoding Bbr_0140 This study
Cm, chloramphenicol.
Table 2 Oligonucleotide primers used in this study
Primer Sequence (5’-3’) Comments
pTX48-
F
AGCCCATGGGCGATAAAATTATTCACCTGACT Forward primer of trxA
pTX48-
R
AGCCTGCAGGATCCCTTGTCGTCGTCGTCACCAGAAGAATGATGATGATGATGGTGCATATGGCCAGAAC Reverse primer of trxA flanked by an
enterokinase cleavage site and a His-tag
pTX49-
R
AGCCTGCAGGATCCCATATGGCCAGAACCAGAAC Reverse primer of trxA
UAL-F AGCAGCCATGGCAGAACATTTTATAAC Forward primer of bppU for pNZ8048
UAL-R AGCAGCACTAGTTTAGTGATGGTGATGGTGATGATTCCGATAAAGTTTTACAATC Reverse primer of bppL for pNZ8048
UALX-
F
AGCAGCGGATCCATGACAGAACATTTTATAAC Forward primer of bppU for pTX8048
UALX-
R
AGCAGCACTAGTTTAATTCCGATAAAGTTTTACAATC Reverse primer of bppL for pTX8048
orf40-F AGCAGCCCATGGGGCGGCTACTAAGTCGCCACTTGCATAAAT Forward primer of orf40 for pNZ8048
orf40-R AGCAGCACTAGTTTAGTGATGGTGATGGTGATGTAAGTGATAGCCATAAGCAA Reverse primer of orf40 for pNZ8048
orf40X-
F
AGCAGCGGATCCATGGGGCGGCTACTAAGTCGCCACTTGCATAAAT Forward primer of orf40 for pTX8048
orf40X-
R
AGCAGCACTAGTTTATAAGTGATAGCCATAAGCAA Reverse primer of orf40 for pTX8048
0140N-
F
TGCATCCCATGGATCATCACCATCACCATCACCATCACCATCACAGCCGGATTCTCAAGGAC Forward primer of bbr_0140 for
pNZ8048
0140N-
R
TGCGCATCTAGATTATGCGATGTAGCTTTC Reverse primer of orf40 for pNZ8048
0140C-
F
AATTAACCATGGGCCGGATTCTCAAGGACAAGC Forward primer of bbr_0140 for
pNZ8048
0140C-
R
TGCCGTTCTAGATTAGTGATGGTGATGGTGATGGTGATGGTGATGTGCGATGTAGCTTTCGATGTGTAG Reverse primer of bbr_0140 for pNZ8048
0140X-
F
GACAAGGGATCCATGAGCCGGATTCTCAAG Forward primer of bbr_0140 for pTX8048
0140X-
R
AGCTCTCTAGATTATGCGATGTAGCTTTC Reverse primer of bbr_0140 for pTX8048
In italic font, are indicated the sequencer encoding enterokinase cleavage site. In bold font, are indicated the polyhistidine tag-encoding sequence. The
restriction sites are underlined.
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® plasmid pETG-20a and flanked with a poly-
histidine tag and an enterokinase cleavage site by PCR
using primers pTX48-F and pTX48-R (Table 2). The
resulting DNA amplicon was double-digested by NcoI
and PstI, and then ligated to the similarly digested
pNZ8048 plasmid (Figure 1). The ligation product was
transformed into L. lactis NZ9000 and screened by col-
ony PCR, and verified by restriction and sequencing
analyses. The plasmid pTX8049 was constructed follow-
ing a similar cloning strategy using primers pTX48-F
and pTX49-R (Figure 1 and Table 2).
Construction of expression vectors encoding thioredoxin
fusion proteins
The gene encoding the Tuc2009 phage protein Tuc2009
ORF40 [29] was amplified from Tuc2009 DNA and
flanked with a C-terminal hexa-histidine tag using pri-
mers orf40-F and orf40-R. The PCR product was
digested with NcoI and SpeI and then ligated to
pNZ8048 cut with NcoI and SpeI.T h el i g a t i o np r o d u c t
was transformed by electroporation into NZ9000 and
screened by colony PCR, prior to restriction and
sequencing analyses. Similarly, Tuc2009 orf40 was
amplified using orf40X-F and orf40X-R, and cloned into
the BamHI and SpeI sites of pTX8048. The restriction
site BamHI in pTX8048 but also pTX8049 allows the
in-frame cloning of a gene of interest, as shown in Fig-
ure 1. The three genes encoding the components of the
Tuc2009 phage baseplate, i.e. bbpU, bppA and bppL,
were amplified from Tuc2009 DNA and flanked with a
C-terminal hexa-histidine tag using primers UAL-F and
UAL-R. The PCR product was digested with NcoI and
Figure 1 Maps and sequence overview of pTX8048 and pTX8049. (A) Vector maps of pTX8048 and pTX8049, which were constructed by
insertion of the E. coli thioredoxin gene trxA, an enterokinase-specific cleavage site and a hexahistidine-tag as illustrated; (B) DNA sequence
overview of the multiple cloning sites of pTX8048 and pTX8049. PnisA, nisin-inducible promoter; RBS, ribosome binding site; trxA, E. coli
thioredoxin A-encoding gene; MCS, multiple cloning site; term, transcriptional terminator; Cm, chloramphenicol cassette. All restriction sites
shown here are unique and can be used as cloning sites. The restriction site BamHI in pTX8048 and pTX8049 allows the in-frame cloning of the
gene of interest.
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Similarly, the DNA region encompassing bppU, bppA
and bppL was amplified using UALX-F and UALX-R,
and then cloned into the BamHI and SpeI sites of
pTX8048. The gene encoding the Bbr_0140 gene pro-
duct was amplified from Bifidobacterium breve
UCC2003 genomic DNA [30] and flanked with either a
C- or an N-terminal hexa-histidine-encoding tag using,
respectively, primer combinations 0140C-F and 0140C-
R, or 0140N-F and 0140N-R. The PCR product was
digested with NcoI and XbaI, and cloned into pNZ8048
cut with NcoI and XbaI. Similarly, Bbr_0140 was ampli-
fied using 0140X-F and 0140X-R, and subsequently
cloned into BamHI and XbaI-restricted pTX8048.
Protein expression assay
L. lactis NZ9000 cells harbouring one of the various
plasmid constructs described in the Methods section
were propagated overnight at 30°C in M17 broth [25]
containing 0.5% (w/v) D-glucose and supplemented with
5 μg/ml chloramphenicol. Fresh GM17 media supple-
mented with 5 μg/ml chloramphenicol was inoculated
with a 1/50 (v/v) overnight liquid culture and incubated
at 30°C. When the optical density at 600 nm reached
0.4, protein expression was induced by the addition of
n i s i nt oaf i n a lc o n c e n t r a t i o no f0 . 2 %( v / v )[ 3 1 ] .L i q u i d
culture was further incubated at 30°C for 4 hours and
bacterial cells were harvested by centrifugation (3000 ×
g for 20 min at 4°C). Bacterial cell pellets were washed
in 50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole,
pH 8.0 and stored at -80°C until further use [31].
Fractionation, SDS-PAGE, immunoblotting analysis and
protein assays
Protein samples were prepared as described by Bahey-
El-Din et al. [31]. Bacterial pellets were resuspended in
50 mM NaH2PO4,3 0 0m MN a C l ,1 0m Mi m i d a z o l e ,
pH 8.0 supplemented with 30 mg/ml lysozyme and
incubated for 30 min on ice. Cell preparations were
then sonicated (8 × 10 sec with 10 sec on ice between
each cycle) at maximum amplitude (MSE Soniprep 150,
Sanyo). Insoluble and soluble fractions were separated
by centrifugation at 14, 000 × g for 10 min at 4°C and
stored at -20°C for further analysis. Sodium dodecyl sul-
fate-polyacrylamide gel electrophoresis (SDS-PAGE) was
performed as previously described [32]. Proteins from
12.5% acrylamide gels were then transferred onto a PVD
membrane (Millipore, UK) by electroblotting [33].
Mouse polyclonal antibodies directed against the poly-
histidine tag or rabbit polyclonal antibodies directed
against BppU, BppA and BppL were used as primary
antibody [26]. Monoclonal anti-mouse or anti-rabbit
antibodies coupled to horseradish-peroxidase (Sigma,
USA) were used as secondary antibody. The membrane
was developed using hydrogen peroxide and 4-chloro-1-
naphthol (Sigma). His-tagged proteins were purified
using the PrepEase
® Histidine-tagged Protein Purifica-
tion kit (USB, OH, USA). Protein content was measured
using the Bio-Rad Protein Assay (Germany), based on
the Bradford protein quantification method.
Enzymatic cleavage of TrxA fusion proteins using
enterokinase
The fusion protein TrxA-Bbr_0140 was expressed and
His-tagged purified as described above. Purified entero-
kinase from calf intestine (Roche GmbH, Germany) was
used to cleave TrxA-Bbr_0140 according to manufac-
turer’s instructions. TrxA-Bbr_0140 was dialyzed against
50 mM Tris buffer, pH 8.0, since phosphate buffer is
known to significantly reduce enterokinase activity as
indicated in the user’s manual. Typically, 25 μgT r x A -
Bbr_0140 was incubated with 0.6 μg enterokinase for 16
h at 20°C or 37°C (enterokinase: TrxA-Bbr_0140 ratio =
1:42). We tested the effect of SDS on enterokinase clea-
vage efficiency as recommended in the manufacturer’s
manual, by supplementing the reaction mixture with
0.1% (w/v) SDS. An equal volume of 2X SDS-PAGE
loading buffer was added and the samples were boiled
at 95°C for 5 min to inactivate enterokinase. The
cleaved protein products were analyzed by SDS-PAGE.
Results and discussion
Description of the two L. lactis thioredoxin-fusion
expression vectors
The two L. lactis thioredoxin-fusion expression vectors,
called pTX8048 and pTX8049 (Figure 1) were employed
in an attempt to express a number of proteins encoded
by the lactococcal phage Tuc2009 and B. breve
UCC2003. The anticipated translational fusions in both
plasmids are placed under the transcriptional control of
the nisin-inducible promoter PnisA,e n s u r i n gat i g h t
control of protein expression in L. lactis [3]. The origi-
nal ribosome binding site present in plasmid pNZ8048
was retained to ensure efficient translation of the fusion
protein (Figure 1) as it had previously been reported
that low expression of proteins may be due to inefficient
translational initiation of mRNA [34]. The E. coli thiore-
doxin trxA represents the N-terminal portion of the
fusion protein (Figure 1), promoting an efficient initia-
tion of translation as previously described [13]. In addi-
tion, plasmid pTX8048 has been designed to join the
thioredoxin C-terminus to the recombinant protein N-
terminus with an amino-acid linker (SSGDDDDKGS)
adapted from LaVallie et al. [19], consisting of serine
(S), glycine (G), aspartic acid (D) and lysine (K) residues
and a highly-specific enterokinase cleavage site
(DDDDK) previously used in an E. coli thioredoxin
fusion system [19] (Figure 1). The (SSG)X5(GS) residues
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ing the thioredoxin C-terminus to the recombinant pro-
tein N-terminus. It facilitates access to the enterokinase
cleavage site (DDDDK), to facilitate release of the
mature protein [35]. In pTX8048, the thioredoxin-speci-
fying sequence was modified to include a C-terminal
hexa-histidine encoding tag, also termed ‘Histidine-
patch thioredoxin’ in the originally developed E. coli
fusion expression systems [36,37] enabling the purifica-
tion of the fusion protein by Ni-TED affinity chromato-
graphy. The thioredoxin and the hexa histidine-tag are
located upstream of the enterokinase cleavage site and
can therefore be removed from the protein of interest
(Figure 1). In comparison, pTX8049 only contains the E.
coli thioredoxin gene trxA followed by a multiple clon-
ing site to insert a gene of interest in an in-frame man-
ner (Figure 1). The lack of additional purification tags
or linkers in pTX8049 allows a greater level of flexibility
in designing and constructing original fusion proteins, i.
e. addition, choice and location of purification tags [13],
peptide linkers [38] and specific cleavage sites (tobacco
etch virus protease cleavage site, thrombin or factor Xa)
[35] (Figure 1). Methods and performances to over-pro-
duce proteins using pTX8049 are identical to pTX8048,
as they both share the same pNZ8048 backbone and
range of bacterial expression hosts.
Production of Tuc2009 ORF40 as a fusion protein
In E. coli but also in L. lactis, the production of small
proteins or peptides is often problematic, as proteins
can be subject to degradation or can aggregate into
inclusion bodies. Tuc2009O R F 4 0i sas m a l lp r o t e i n
(7.65 kDa) with no known function and encoded by the
lactococcal phage Tuc2009. We initially attempted to
express the C-terminal His-tagged Tuc2009 ORF40
using the vector pNZ8048 in which ORF40 was cloned.
The size of Tuc2009 ORF40 does not allow its detection
by SDS-PAGE as the corresponding band would have
been masked by the large amount of lyzozyme (14 kDa)
required to lyse L. lactis NZ9000 (Figure 2, panel A).
However, further immunoblotting analysis and Ni-TED
affinity chromatography indicated that Tuc2009 ORF40
was not expressed in either soluble or insoluble form in
NZ9000 (data not shown). We constructed the vector
pTX8048-40 to express the fusion protein TrxA-
Tuc2009 ORF40. Expression assays of TrxA-ORF40 in
NZ9000 are shown in Figure 2. A distinct band corre-
sponding to TrxA-ORF40 (21.8 kDa) was observed in
the soluble fraction (Figure 2, panel A). Subsequently,
TrxA-ORF40 was successfully purified by Ni-TED chro-
matography - availing of the peptide linker of pTX8048
containing a His-tag patch - and the total soluble frac-
tion was analyzed by immunoblotting using anti-poly
histidine antibodies (Figure 2, panels B and C). Using
the thioredoxin fusion gene expression vector pTX8048,
similar results were obtained for other small phage pro-
teins, such as Tuc2009 ORF41 (12.8 kDa) and Tuc2009
ORF43 (11.9 kDa), where initial expression attempts
using the original pNZ8048 NICE vector had also failed
(data not shown). These results clearly demonstrate that
small proteins when fused to the E. coli thioredoxin can
be efficiently expressed in L. lactis.
Production and purification of the Tuc2009 phage
baseplate in L. lactis NZ9000
Recombinant proteins may be improperly folded, pre-
venting interactions with their protein partner(s). Such
problems hamper further characterization of large
Figure 2 Production of a small phage protein encoded by Tuc2009 ORF40. (A) Protein gel analysis of soluble fractions of NZ9000 +
pTX8048-40 without nisin induction (lane 1), and after induction with 0.2% (v/v) nisin (lane 2), soluble fraction of NZ9000 + pNZ8048-40 after
0.2% nisin induction (lane 3). (B) Protein gel of purified Tuc2009 ORF40 from NZ9000 + pTX8048-40. Lanes: L, prestained marker; 1-3, elution
fractions. (C) Immunoblotting analysis showing Tuc2009 ORF40 using mouse anti-polyhistidine antibody as primary antibody. The Tuc2009 ORF40
protein product is indicated by an arrow.
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tein-protein interactions m a yb ep r e v e n t e d .T h eb a s e -
plate (Bpp) of Tuc2009 is a large multimeric protein
complex involved in host recognition [39-43]. It consists
of three proteins: the upper baseplate (BppU), the asso-
ciated baseplate (BppA) and the lower baseplate (BppL)
[26,41]. Although a low-resolution model of the Bpp
complex has been proposed [41], the fine details of its
intimate structure are not yet fully understood. Further
functional and structural analyses of Bpp would be
greatly facilitated if the Bpp complex could be over-
expressed. Initial attempts to over-express the Bpp com-
plex in L. lactis using the vector pNZ8048 in which the
corresponding genes of the Bpp complex had been
cloned demonstrated that BppU, BppA and BppL were
produced, although at low levels. However, subsequent
purification attempts did not allow the co-purification of
the three Bpp complex components, i.e. BppU, BppA
and BppL (data not shown). In Tuc2009 and also the
closely related lactococcal phage TP901-1, the baseplate
complex is associated with the initiation complex and
the baseplate component BppU has been reported to be
particularly vulnerable to degradation [41]. It was hoped
that production of the Bpp complex, where BppU is
fused to thioredoxin, would stabilize the Bpp complex,
and that the presence of the His-tag in the peptide lin-
ker would facilitate co-purification of the heteromeric
Bpp complex. In order to test this idea, plasmid
pTX8048-UAL was generated and tested for Bpp com-
plex expression and purification. Following induction,
and cell lysis, total soluble protein fraction was resolved
by SDS-PAGE (Figure 3). Although only one band cor-
responding to BppL (18.8 kDa) was visually detected in
this way, further purification and immunoblotting
analyses indicated that TrxA-BppU (50.4 kDa) and
BppA (31.85 kDa) and BppL were all expressed and
could be co-purified as a complex by affinity chromato-
graphy availing of the hexahistidine-tag of TrxA-BppU
(Figures 3 and 4). Immunoblotting analysis was per-
formed to check the integrity of the over-expressed pro-
teins (Figure 4), which indicated the apparent absence of
any degradation and/or sub-products. This result clearly
demonstrated that the L. lactis Trx-fusion expression
system is also suitable for the production and purifica-
tion of intact heteromultimeric protein complexes.
Over production of Bifidobacterium breve UCC2003
Bbr_0140 using pTX8048
In an effort to demonstrate the versatility of our thiore-
doxin system, we also attempted to over-produce a pro-
tein encoded by a bacterium that is unrelated to L.
lactis. Bbr_0140 specifies a 200 amino-acid protein (23.5
kDa) encoded by the Bifidobacterium breve UCC2003
genome [30]. We initially attempted to express either C-
or N-terminally His-tagged Bbr_0140 using the standard
expression vector pNZ8048 in which we had cloned the
coding sequence of Bbr_0140. However, using this
expression system no Bbr_0140 protein product was
detected by SDS-PAGE (Figure 5, panel A). We there-
fore constructed pTX8048-0140 to express the fusion
protein TrxA-Bbr_0140 as described in Methods.
Expression assays of TrxA-ORF40 in NZ9000 are shown
in Figure 5. A distinct band corresponding to TrxA-
Bbr_0140 (37.5 kDa) was observed in the soluble frac-
tion, clearly demonstrating that TrxA-Bbr_0140 was
successfully over-produced, while further analysis
showed that this protein could be purified by Ni-TED
affinity chromatography and visualized by immunoblot-
ting using anti-poly histidine antibodies as a primary
antibody (Figure 5, panels B and C). These results show
Figure 3 Co-production of the Tuc2009 baseplate components
BppU, BppA and BppL. (A) Protein gel analysis of soluble fractions
of NZ9000 + pTX8048-UAL without nisin induction (lane1), NZ9000
+ pNZ8048-UAL following induction with 0.2% (v/v) nisin (lane 2)
and NZ9000 + pTX8048-UAL following induction with 0.2% (v/v)
nisin (lane 3). (B) Protein gel of Ni-affinity purified baseplate
complex from NZ9000 + pTX8048-UAL soluble fraction. Lanes: L,
prestained marker; 1, flow-through; 2-3, elution fractions.
Figure 4 Immunoblotting analysis of Tuc2009 baseplate
components BppU, BppA and BppL. Lanes: L, prestained marker.
Immunoblotting analysis showing BppU, BppA and BppL using,
respectively, anti-BppU, anti-BppA and anti-BppL rabbit polyclonal
antibody as primary antibody. BppU, BppA and BppL are indicated
by arrows.
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suitable to produce heterologous proteins from a com-
pletely unrelated bacterial origin.
Enterokinase cleavage of the thioredoxin fusion protein
TrxA-Bbr_0140
The presence of a cleavage site is an important feature
of this Trx-fusion expression system, as it allows the
cleavage and release of the thioredoxin moiety from its
fused protein of interest. Our vector pTX8048 possesses
a peptide linker containing an enterokinase cleavage site
(DDDDK) that connects the thioredoxin to the C-termi-
nus of the fused protein. To test whether we could
remove the Trx-moiety, purified thioredoxin-Bbr_0140
fusion protein was incubated with calf intestine entero-
kinase as described in the Methods section. As shown in
Figure 6 (panel A), the thioredoxin-Bbr_0140 fusion
protein was efficiently and specifically cleaved, as two
products of 23.5 kDa and 14 kDa corresponding to the
mature Bbr_0140 protein and the thioredoxin- linker
product, respectively, were clearly observed by SDS-
PAGE. The supplementation of the cleavage mixture
with 0.1% (w/v) SDS did not improve the cleavage effi-
ciency (Figure 6, panel A), indicating that the enteroki-
nase cleavage site is equally accessible and cleavable in
native and denaturing conditions. Further applications
will dictate what cleavage conditions can be used. Under
native conditions, subsequent purification of the cleaved
Bbr_0140 protein was performed using Ni-TED chroma-
tography. His-tagged thioredoxin-linker and uncleaved
fusion proteins were retained on the nickel resins,
whereas cleaved mature proteins were collected in the
flow-through (Figure 6, panel B). However, the purified
samples will still contain the enterokinase contaminant,
although its corresponding band can not be observed on
the protein gel (Figure 6, panel B). Additional/alternative
chromatography techniques may be considered, such as
ion exchange chromatography or gel filtration to further
purify the mature protein following thioredoxin cleavage
by removing the enterokinase contaminant [19]. Alter-
natively, the use of commercially available his-tagged
enterokinase could also be considered and implemented
to the purification procedure described in this study.
Using the Bio Rad Protein Quantification Assay, we
measured an average yield of 1.2 mg per litre of culture
of purified Bbr_0140. It is noteworthy that protein yields
are protein-dependent and not every protein will be
expressed at the same level using pTX8048 and
pTX8049. Mierau and colleagues previously reported
that the original NICE system allows the production of
Figure 5 Production of B. breve protein Bbr_0140. (A) SDS-PAGE analysis of soluble fractions of NZ9000 + pTX8048-0140 without nisin
induction (lane1), and following induction with 0.2% (v/v) nisin (lane 2), soluble fraction of NZ9000 + pNZ8048-0140C following 0.2% nisin
induction (lane 3) and soluble fraction of NZ9000 + pNZ8048-0140N following 0.2% nisin induction (lane 4). (B) SDS-PAGE analysis of purified
Bb_0140 from cell extracts of NZ9000 + pTX8048-0140 following 0.2% nisin induction. Lanes: L, prestained marker; 1-3, elution fractions. (C)
Immunoblotting analysis showing Bbr_0140 using mouse anti-polyhistidine antibody as primary antibody. Bbr_0140 is indicated by an arrow.
Figure 6 Cleavage of the thioredoxin-Bbr_0140 fusion protein
by enterokinase. (A) Protein gel analysis of purified TrxA-Bbr_0140
incubated for 16 h at 20°C without enterokinase (lane 1), incubated
for 16 h at 37°C with enterokinase (lane 2), incubated for 16 h at
37°C with enterokinase and 1% (v/v) SDS (lane 3), incubated for 16
h at 20°C with enterokinase and 1% (v/v) SDS (lane 4). (B) Protein
gel analysis of purified Bbr_0140 after cleavage (lane1) and after
cleavage and subsequent purification (lane 2).
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phin per liter of culture on a industrial scale [1].
Although the yields of production shown are signifi-
cantly lower using our thioredoxin gene fusion systems,
it is still a valuable tool as it allows the expression of
soluble proteins that could not be expressed with the
original NICE system. Also, the adjustment of key pro-
tein-specific parameters, such as medium composition
and fermentation conditions could significantly improve
the production yield of the target protein. The design
and incorporation of an enterokinase cleavage site in
pTX8048 is shown to be functional and further purifica-
tion allows the final production of native and soluble
heterologous proteins in L. lactis.
Conclusions
The thioredoxin gene fusion system represents an
attractive system to over-produce and purify proteins in
L. lactis that exhibit poor or no expression, or produce
insoluble proteins using conventional expression vectors.
In this study, we have described the construction of an
L. lactis Trx-fusion expression system and demonstrated
its applicability by over-producing and purifying various
proteins or complexes as soluble thioredoxin fusions.
The benefits of the original E. coli thioredoxin fusion
expression system have previously been demonstrated
[18,19], and in this report we have shown that these are
also applicable to the expression host L. lactis,w h e n
combined with the NICE system. This expression and
purification tool offers a wide spectrum of applications
in L. lactis and also other Gram-positive bacteria that
can accommodate the NICE system, such as L. plan-
tarum [44]. Although our study does not show the func-
tionality of the overexpressed proteins, we are confident
that the majority of such proteins are biologically active
as based on numerous peer-reviewed studies using the
original NICE system, as reviewed by Mierau et al.[ 1 ] .
The protein production levels obtained in L. lactis using
the thioredoxin fusion gene expression system allow
further structural and biochemical analysis, such as X-
ray crystallography analysis, antibody production, pro-
tein-protein interaction assays, and enzymatic assays.
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